Swiss neurotechnology startup Neurosoft Bioelectronics made a remarkable impression during CES 2026 in Las Vegas, capturing two major international awards…

The Biopôle-based global MedTech company, which created the surgeon robot Dexter announced a strategic investment from Johnson & Johnson.

University of Geneva Faculty of Medicine has launched the Geneva Centre for Cardiac and Vascular Research (GCCVR).

Three EPFL-born startups receive key funding to advance breakthrough technologies in health and biology.

Reverso Therapeutics, a University of Geneva (UNIGE) pharmaceutical spin-off, and winner of the Bioinnovation Day Best Academic Project Award 2025, has been awarded a CHF 710,000 grant from Innosuisse to accelerate the development of its breakthrough reversible anticoagulant technology.

The Jura-based medtech startup Altiscreen has obtained CHF 150,000 from Venture Kick to build a portable drug-testing solution that delivers…

Two Tech Seed loans of CHF 100,000 each were awarded by FIT to Databaum , an artificial intelligence platform for…

Two projects from the University of Geneva and one project from CERN have each been awarded CHF 50,000 in funding…

Bio-Techne (formerly Lunaphore) has announced a strategic partnership between its spatial biology brand Lunaphore and the Wyss Center Geneva to…

DigeHealth SA, a Swiss medtech company developing a wearable device that “listens to the gut” to support early detection and…

Led by Isa Dupont, a nurse, and Gaspard Chevassus, an engineer, the StudentsPool project is reinventing ad hoc recruitment and…

EspeRare, a pioneering Geneva-based nonprofit biotech, announced that it has been awarded a Grand Challenges grant from the Gates Foundation….